Kumarappan Chidambaram

3.0k total citations · 1 hit paper
106 papers, 2.1k citations indexed

About

Kumarappan Chidambaram is a scholar working on Molecular Biology, Plant Science and Pharmacology. According to data from OpenAlex, Kumarappan Chidambaram has authored 106 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 17 papers in Plant Science and 14 papers in Pharmacology. Recurrent topics in Kumarappan Chidambaram's work include Natural Antidiabetic Agents Studies (12 papers), Wound Healing and Treatments (7 papers) and Advanced Drug Delivery Systems (6 papers). Kumarappan Chidambaram is often cited by papers focused on Natural Antidiabetic Agents Studies (12 papers), Wound Healing and Treatments (7 papers) and Advanced Drug Delivery Systems (6 papers). Kumarappan Chidambaram collaborates with scholars based in Saudi Arabia, India and Malaysia. Kumarappan Chidambaram's co-authors include Subhash C. Mandal, Ellappan Thilagam, M. Yasmin Begum, P.S. Rajinikanth, Talha Bin Emran, Dilip Kumar Arya, Prashant Pandey, Saikat Mitra, Vetriselvan Subramaniyan and Nur Najihah Izzati Mat Rani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Molecules.

In The Last Decade

Kumarappan Chidambaram

101 papers receiving 2.0k citations

Hit Papers

A Comprehensive Review on... 2022 2026 2023 2024 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin
    2022 234 citations Shivkanya Fuloria, Jyoti Mehta et al. Frontiers in Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kumarappan Chidambaram Saudi Arabia 24 528 325 288 286 236 106 2.1k
Rubiya Khursheed India 28 498 0.9× 289 0.9× 264 0.9× 227 0.8× 265 1.1× 67 2.0k
Arun Kumar India 27 641 1.2× 233 0.7× 318 1.1× 303 1.1× 235 1.0× 102 2.4k
Shivkanya Fuloria Malaysia 30 853 1.6× 280 0.9× 223 0.8× 169 0.6× 270 1.1× 130 2.8k
Vetriselvan Subramaniyan Malaysia 32 960 1.8× 361 1.1× 345 1.2× 211 0.7× 384 1.6× 187 3.3k
Neeraj Kumar Fuloria Malaysia 32 993 1.9× 300 0.9× 269 0.9× 175 0.6× 373 1.6× 161 3.2k
Mohamed M. Elmazar Egypt 31 796 1.5× 223 0.7× 294 1.0× 201 0.7× 176 0.7× 104 2.9k
Shubhini A. Saraf India 27 734 1.4× 294 0.9× 448 1.6× 141 0.5× 189 0.8× 163 2.9k
Baddireddi Subhadra Lakshmi India 27 890 1.7× 350 1.1× 336 1.2× 291 1.0× 188 0.8× 73 2.1k
Abeer Salama Egypt 30 625 1.2× 244 0.8× 248 0.9× 144 0.5× 136 0.6× 165 2.8k
Ankit Awasthi India 26 408 0.8× 242 0.7× 155 0.5× 227 0.8× 133 0.6× 70 1.6k

Countries citing papers authored by Kumarappan Chidambaram

Since Specialization
Citations

This map shows the geographic impact of Kumarappan Chidambaram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumarappan Chidambaram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumarappan Chidambaram more than expected).

Fields of papers citing papers by Kumarappan Chidambaram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumarappan Chidambaram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumarappan Chidambaram. The network helps show where Kumarappan Chidambaram may publish in the future.

Co-authorship network of co-authors of Kumarappan Chidambaram

This figure shows the co-authorship network connecting the top 25 collaborators of Kumarappan Chidambaram. A scholar is included among the top collaborators of Kumarappan Chidambaram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumarappan Chidambaram. Kumarappan Chidambaram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chinnam, Sampath, Guddekoppa S. Ananthnag, Kumarappan Chidambaram, et al.. (2025). Design, synthesis, crystal structure of novel hydrazone analogues as SARS-CoV-2 potent inhibitors: MD simulations, MM-GBSA, docking and ADMET studies. Royal Society Open Science. 12(7). 1 indexed citations
2.
Radhakrishna, G., B.S. Hemanth Kumar, Sunil B. Nagaraj, et al.. (2025). Development and evaluation of S-carboxymethyl-L-cystine-loaded solid lipid nanoparticles for Parkinson’s disease in murine and zebrafish models. Scientific Reports. 15(1). 10885–10885. 5 indexed citations
3.
Chidambaram, Kumarappan, Arcot Rekha, Ahsas Goyal, & Mohit Rana. (2025). Targeting KRAS-G12C in lung cancer: The emerging role of PROTACs in overcoming resistance. Pathology - Research and Practice. 270. 155954–155954. 2 indexed citations
4.
Saleem, Shakir, et al.. (2025). Immunoassay-based biomarkers in atopic dermatitis. Clinica Chimica Acta. 579. 120634–120634. 1 indexed citations
5.
6.
Asiri, Yahya I., et al.. (2024). An Integrated Computational and Experimental Approach to Formulate Tamanu Oil Bigels as Anti-Scarring Agent. Pharmaceuticals. 17(1). 102–102. 6 indexed citations
7.
Sabarathinam, Sarvesh, et al.. (2024). Isolation of 6-gingerol and semi-synthesis of 1,4-benzodiazepines derivatives: An in-situ pharmacokinetics properties, molecular docking and molecular dynamics simulation assessments. Saudi Journal of Biological Sciences. 31(8). 104048–104048. 6 indexed citations
8.
9.
Tailang, Mukul, Balakumar Chandrasekaran, Biswa Mohan Sahoo, et al.. (2023). Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review. Frontiers in Pharmacology. 14. 1135145–1135145. 21 indexed citations
10.
Pandey, Prashant, Dilip Kumar Arya, Ravi Gupta, et al.. (2023). Multilayered nanofibrous scaffold of Polyvinyl alcohol/gelatin/poly (lactic-co-glycolic acid) enriched with hemostatic/antibacterial agents for rapid acute hemostatic wound healing. International Journal of Pharmaceutics. 638. 122918–122918. 60 indexed citations
11.
Sekar, Mahendran, Shivkanya Fuloria, M. Yasmin Begum, et al.. (2022). Chemistry, Biosynthesis and Pharmacology of Sarsasapogenin: A Potential Natural Steroid Molecule for New Drug Design, Development and Therapy. Molecules. 27(6). 2032–2032. 22 indexed citations
12.
Rahman, Md. Mominur, Md. Rezaul Islam, Sheikh Shohag, et al.. (2022). The Multifunctional Role of Herbal Products in the Management of Diabetes and Obesity: A Comprehensive Review. Molecules. 27(5). 1713–1713. 111 indexed citations
13.
14.
Arya, Dilip Kumar, Prashant Pandey, Sneha Anand, et al.. (2022). ECM Mimicking Biodegradable Nanofibrous Scaffold Enriched with Curcumin/ZnO to Accelerate Diabetic Wound Healing via Multifunctional Bioactivity. International Journal of Nanomedicine. Volume 17. 6843–6859. 41 indexed citations
15.
Ashraf, Rizwan, Krishnaraju Venkatesan, Krishnaraju Venkatesan, et al.. (2021). Social Support, Self-Care Behaviour and Self-Efficacy in Patients with Type 2 Diabetes during the COVID-19 Pandemic: A Cross-Sectional Study. Healthcare. 9(11). 1607–1607. 16 indexed citations
16.
Mareeswaran, Paulpandian Muthu, et al.. (2021). Synthesis and Photoluminescence Properties of MoS 2 /Graphene Heterostructure by Liquid-Phase Exfoliation. ACS Omega. 7(1). 629–637. 21 indexed citations
17.
Chidambaram, Kumarappan, et al.. (2021). In vitro cytotoxicity and in vivo acute oral toxicity evaluation of coptis chinensis aqueous extract. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Alqahtani, Ali, et al.. (2020). Understanding the genetic aspects of resistance to antidepressants treatment.. PubMed. 24(14). 7784–7795. 7 indexed citations
19.
Ramamurthy, S, et al.. (2013). Investigation on antimicrobial activity of root extracts of Thespesia populnea Linn.. PubMed. 30(4). 570–8. 4 indexed citations
20.
Chidambaram, Kumarappan, et al.. (2008). Inhibition of Carbohydrate Digestive Enzymes by Talinum portulacifolium (Forssk) Leaf Extract. Journal of Complementary and Integrative Medicine. 5(1). 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rubiya Khursheed Breakdown of academic impact, for papers by Arun Kumar Breakdown of academic impact, for papers by Shivkanya Fuloria Breakdown of academic impact, for papers by Vetriselvan Subramaniyan Breakdown of academic impact, for papers by Neeraj Kumar Fuloria Breakdown of academic impact, for papers by Mohamed M. Elmazar Breakdown of academic impact, for papers by Shubhini A. Saraf Breakdown of academic impact, for papers by Baddireddi Subhadra Lakshmi Breakdown of academic impact, for papers by Abeer Salama Breakdown of academic impact, for papers by Ankit Awasthi
Rankless by CCL
2026